Enteric fever, a systemic illness primarily caused by Salmonella Typhi and Paratyphi, remains a significant public health issue globally. This article aims to provide an updated approach to the diagnosis and management of enteric fever, focusing on recent developments and current best practices.
Diagnosis of enteric fever is challenging due to its nonspecific symptoms and the limitations of current diagnostic tests. Blood culture remains the gold standard for diagnosis, but its sensitivity is diminished in the early stages of the disease. Recent advances include the development of molecular diagnostic techniques such as PCR and the use of serological tests like Typhidot and Tubex TF. However, these tests still have limitations in terms of sensitivity and specificity, and further research is needed to validate their use in clinical practice.
The management of enteric fever has been complicated by the increasing prevalence of antibiotic resistance. Current guidelines recommend the use of fluoroquinolones as the first-line treatment, but resistance to these agents is increasing. Therefore, alternative antibiotics such as azithromycin and third-generation cephalosporins are now being recommended. Vaccination also plays a crucial role in the prevention of enteric fever, particularly in endemic areas. However, the currently available vaccines have limitations and there is a need for the development of more effective vaccines.
In conclusion, the diagnosis and management of enteric fever pose significant challenges due to nonspecific symptoms, limitations of diagnostic tests, and increasing antibiotic resistance. It is crucial for healthcare professionals to stay updated on the latest developments in this field to ensure the effective management of patients with enteric fever. Future research should focus on the development of more sensitive and specific diagnostic tests and more effective vaccines.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation